Linnea – A pioneering pharmaceutical manufacturing excellence

Founded in 1982, Linnea stands among the leading Swiss manufacturers of premium active pharmaceutical ingredients (APIs) derived from botanicals. With over 40 years of expertise, we remain committed to innovation, quality, and sustainability. Operating from our GMP-certified facility and following GACP guidelines, we strive to ensure exceptional product standards and consistency. Our fully validated manufacturing processes use the finest raw materials sourced from trusted international cultivators and suppliers. Stringent controls and industry-leading standardized production deliver batch-to-batch consistency at all times, guaranteeing a highly reliable quality and performance, along with a steady focus on ESG principles.
Serving 300+ clients in over 70 countries, we offer customized regulatory and scientific support tailored to market needs. Linnea’s fully in-house research, its academic collaborations, and a strong commitment to scientific advancement drive continuous improvement and innovation, ensuring we remain a trusted partner in the pharmaceutical industry